Table 6. The overall survivals of different BCLC C HCC Prognostic (BCHP) stages in patients with advanced HCC treated with TACE.
Stage | Total score | N (%) | OS* (months) | P value |
---|---|---|---|---|
I | 0–2 | 93 (39.1) | 28.4 | <0.001 |
II | 3–5 | 135 (56.7) | 11.8 | |
III | >5 | 10 (4.2) | 2.4 |
OS*–Overall survival